Literature DB >> 12213612

Brain glucose metabolism in Rett Syndrome.

Patricia M Villemagne1, Sakkubai Naidu, Victor L Villemagne, Myron Yaster, Henry N Wagner, James C Harris, Hugo W Moser, Michael V Johnston, Robert F Dannals, Dean F Wong.   

Abstract

Rett syndrome is a progressive neurologic disorder affecting girls in early childhood with loss of achieved psychomotor abilities and mental retardation. Six sedated female patients (4 to 15 years of age) with a diagnosis of Rett syndrome were studied with [(18)F]fluorodeoxyglucose (FDG) and underwent positron emission tomography scanning of the brain. Relative tracer concentrations between different areas of the brain were assessed, and results were compared with 18 age-matched control subjects. Patients were divided into two age groups: 3 to 8 years of age and 9 to 15 years of age. A relative decrease in [(18)F]FDG uptake in the lateral occipital areas in relation with the whole brain and a relative increase in the cerebellum was evident in both age groups (P < 0.001, unpaired Student t test). A relative increase in frontal tracer uptake was observed in the younger group. Sensorimotor areas and relations between cortical and subcortical structures were preserved in all patients. Changes in glucose cerebral metabolism resemble the regional distribution of normal children less than 1 year of age, likely reflecting a maturational arrest. Changes in frontal areas parallel those in postmortem N-methyl-D-aspartate receptor densities and could correlate with different clinical stages of the disease. This pattern differs from those described in Down syndrome, autism, and Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213612     DOI: 10.1016/s0887-8994(02)00399-5

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  7 in total

1.  Has PET become an important clinical tool in paediatric imaging?

Authors:  Klaus Hahn; Thomas Pfluger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-05       Impact factor: 9.236

Review 2.  Nuclear and Cytoplasmatic Players in Mitochondria-Related CNS Disorders: Chromatin Modifications and Subcellular Trafficking.

Authors:  Matteo Gasparotto; Yi-Shin Lee; Alessandra Palazzi; Marcella Vacca; Francesco Filippini
Journal:  Biomolecules       Date:  2022-04-23

3.  Creb1-Mecp2-(m)CpG complex transactivates postnatal murine neuronal glucose transporter isoform 3 expression.

Authors:  Yongjun Chen; Bo-Chul Shin; Shanthie Thamotharan; Sherin U Devaskar
Journal:  Endocrinology       Date:  2013-03-14       Impact factor: 4.736

4.  Brain metabolism in Rett syndrome: age, clinical, and genotype correlations.

Authors:  Alena Horská; Luciano Farage; Genila Bibat; Lídia M Nagae; Walter E Kaufmann; Peter B Barker; SakkuBai Naidu
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

5.  Systemic Radical Scavenger Treatment of a Mouse Model of Rett Syndrome: Merits and Limitations of the Vitamin E Derivative Trolox.

Authors:  Oliwia A Janc; Marc A Hüser; Katharina Dietrich; Belinda Kempkes; Christiane Menzfeld; Swen Hülsmann; Michael Müller
Journal:  Front Cell Neurosci       Date:  2016-11-15       Impact factor: 5.505

6.  RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome.

Authors:  Natasha L Pacheco; Michael R Heaven; Leanne M Holt; David K Crossman; Kristin J Boggio; Scott A Shaffer; Daniel L Flint; Michelle L Olsen
Journal:  Mol Autism       Date:  2017-10-24       Impact factor: 7.509

Review 7.  Multimodal Neuroimaging in Rett Syndrome With MECP2 Mutation.

Authors:  Yu Kong; Qiu-Bo Li; Zhao-Hong Yuan; Xiu-Fang Jiang; Gu-Qing Zhang; Nan Cheng; Na Dang
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.